IQV - IQVIA HOLDINGS INC.


175.06
1.510   0.863%

Share volume: 1,212,913
Last Updated: 05-12-2026
Business Services/Services – Research, Development, Testing Labs: -0.02%

PREVIOUS CLOSE
CHG
CHG%

$173.55
1.51
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
48%
Profitability 31%
Dept financing 50%
Liquidity 13%
Performance 72%
Company vs Stock growth
vs
Performance
5 Days
-2.04%
1 Month
1.78%
3 Months
4.86%
6 Months
-21.69%
1 Year
16.18%
2 Year
-23.57%
Key data
Stock price
$175.06
P/E Ratio 
20.90
DAY RANGE
$170.98 - $176.24
EPS 
$8.12
52 WEEK RANGE
$134.64 - $247.04
52 WEEK CHANGE
$23.44
MARKET CAP 
28.941 B
YIELD 
N/A
SHARES OUTSTANDING 
166.900 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.63
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$2,116,176
AVERAGE 30 VOLUME 
$1,699,694
Company detail
CEO: Ari Bousbib
Region: US
Website: iqvia.com
Employees: 86,000
IPO year: 2013
Issue type: Common Stock
Market: NYSE
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and Asia-Pacific. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services. The Research & Development Solutions segment provides project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services.

Recent news